The single decision that matters most when comparing Overjet to its alternatives is not which vendor has the flashiest AI demo, but which clinical workflow you actually need automated. Pearl, VideaHealth, Denti.AI, and Velmeni are the true head-to-head competitors for chairside 2D pathology detection on bitewing and periapical film. Diagnocat is built specifically for 3D CBCT scans. Orca Dental AI and Dental Monitoring solve narrower, different clinical problems (cephalometric analysis and remote ortho monitoring) rather than caries or perio detection. Adravision is the only alternative attempting Overjet's payer-facing claims angle, at a vastly smaller funding stage. And KELLS and Zentist solve different jobs entirely (consumer discount membership and revenue-cycle billing) despite surfacing in some Overjet alternative searches. Match the tool to the workflow first, then compare price and FDA clearance depth within that narrower set.
TL;DR
Ranked by how closely each product actually competes with Overjet's core AI-powered imaging platform, not by funding size alone.
- Pearl (Second Opinion): one broad FDA clearance covering caries, bone loss, calculus, and more, at a published flat monthly price.
- VideaHealth: Harvard/MIT-founded chairside detection AI with the deepest named DSO customer base (Heartland Dental, dentalcorp).
- Denti.AI: the only vendor here cleared for panoramic-film disease detection specifically, alongside auto-charting.
- Velmeni (V4D): a newer, thinly-documented entrant whose own FDA clearance pathway cites an Overjet filing as its predicate.
- Diagnocat: a CBCT-specific specialist, the direct comparison point for Overjet's own CBCT Assist clearance.
- Orca Dental AI (CephX): a narrower, different clinical use case: AI-assisted orthodontic cephalometric analysis, not general pathology detection.
- Adravision: an early-stage, YC-backed platform targeting clinics, DSOs, and payers at once, at roughly $230K raised.
- Dental Monitoring: a different workflow altogether: AI-based remote patient monitoring between orthodontic visits, not chairside imaging.
- KELLS: a consumer discount-membership and telehealth-triage platform, not enterprise imaging or claims AI.
- Zentist: dental revenue-cycle-management automation for DSOs, an adjacent billing category rather than imaging AI.
How We Evaluated These 10 Overjet Alternatives
With these 7 major criteria we have carefully evaluated every alternative, so you can choose the better Overjet alternative for your practice or DSO.
- Clinical or functional scope: what pathology, condition, or workflow the AI actually detects or automates.
- FDA clearance status, and how independently verifiable the clearance count actually is against FDA.gov.
- Payer-side or claims-facing capability, the pillar of Overjet's own platform that most alternatives do not attempt.
- Integration depth with practice management and imaging systems, by name where the vendor discloses it.
- Company maturity: funding raised, named customers, and years actually in market.
- Pricing transparency: a published price versus a "contact vendor" model.
- Independent review-platform coverage on G2 and Capterra, and whether that coverage is thin or contradictory.
Comparison of Top 10 Overjet Alternatives
| Company | Best fit | Type | FDA clearance | Pricing | Review |
|---|---|---|---|---|---|
| Pearl (Second Opinion) | Practices wanting one broad clearance across many findings | Chairside imaging AI | 1 broad clearance (K210365, third-party-sourced) | $299/month (per Capterra) | 3.5 · 1 · G2; 4.3 · 4 · Capterra |
| VideaHealth | DSOs wanting deep clinical validation and named enterprise customers | Chairside imaging AI | At least 3 clearances (1 confirmed on FDA.gov) | Not published | No score found on G2 or Capterra |
| Denti.AI | Practices wanting panoramic-film detection plus auto-charting | Chairside imaging AI | 2 clearances (vendor press, not independently re-verified) | Not published ($49/month per one third-party site, unconfirmed) | No score found for the imaging product (4.9 · 8 · Capterra is for its separate Voice product) |
| Velmeni (V4D) | Practices open to a newer, less-documented entrant | Chairside imaging AI | 2 clearances per an industry tracker | Not found | No score found on G2 or Capterra |
| Diagnocat | Practices whose priority is 3D CBCT analysis specifically | 3D/CBCT imaging AI | 1 clearance claimed, K-number not disclosed | Not found | No score found on G2 or Capterra |
| Orca Dental AI (CephX) | Orthodontic practices needing cephalometric analysis specifically | Niche specialist AI | 1 clearance (third-party tracker only) | Not found | No score found on G2 or Capterra |
| Adravision | Early adopters wanting a payer-facing angle at small scale | Early-stage payer-facing AI | None found | Not found | No score found on G2 or Capterra |
| Dental Monitoring | Ortho practices wanting between-visit remote monitoring | Niche specialist AI (ortho) | Not applicable (different regulatory profile) | Not published | 0.0 · 0 · Capterra |
| KELLS | Consumers wanting a discounted dentist network, not a practice tool | Adjacent category (consumer) | None found / not applicable | Free/Basic; Premium $99/yr; Complete $149/yr | No score found on G2 or Capterra |
| Zentist | DSOs wanting billing/claims operations automation, not imaging AI | Adjacent category (RCM) | None found / not applicable | Not published | No score found on G2 or Capterra |
Company order matches the TL;DR ranking above. "Not published" and "not found" are stated as facts, not implied reasons; see each profile for sourcing detail.
What Is AI-Powered Dental Imaging Software?
AI-powered dental imaging software uses machine learning models, most FDA-cleared, to scan X-rays or CBCT images and flag caries, bone loss, calculus, and periapical lesions, helping dentists catch pathology sooner and document findings for treatment planning and insurance claim decisions faster.
How Big Is the AI-Powered Dental Imaging Category?
We could not find a dedicated market-size or revenue report specific to AI-powered dental imaging and pathology-detection software, as distinct from the much broader "dental AI" or "AI in dentistry" category that also includes scheduling software, patient chatbots, and generic practice-management tools. Broader "AI in dentistry" market reports exist, but folding them in here would overstate the size of the narrower chairside-imaging-detection and payer-claims-AI category this document actually covers, so we are stating the gap plainly rather than presenting an adjacent number as if it answered the question. What is independently verifiable instead: the funding raised by named vendors in this list (Overjet's stated $130M+, Pearl's $58M Series B, VideaHealth's $40M Series B), and the FDA's own public 510(k) database, which is the most reliable proxy for how active this specific category actually is.
The 10 Overjet Alternatives, in Detail
1. Pearl (Second Opinion)
Best for: practices that want one broad FDA clearance covering many findings at once, at a published flat price.
Pearl, marketed as hellopearl.com, is a chairside AI imaging platform whose flagship product, Second Opinion, holds a single FDA clearance (K210365, cleared around March 2022 per third-party trackers, not independently re-verified against FDA.gov this pass) covering caries, periapical radiolucencies, calculus, crown and filling findings, implants, bridges, root canals, and restoration-margin discrepancies on bitewing and periapical film for patients age 16 and older.
How it delivers pathology detection
Second Opinion runs against a practice's existing 2D X-ray images and returns findings across all covered conditions from one clearance, rather than requiring a separate clearance per finding type, which is how Overjet's own nine clearances are structured.
| Highlighting features | One clearance covers caries, bone loss, calculus, and 5+ other finding types · 40+ claimed system integrations across imaging and PMS platforms · Flat published monthly price with a free trial · $58M Series B (Aug 2024), led by Left Lane Capital |
| Clinical/functional scope | Chairside 2D pathology detection: caries, bone loss, calculus, root canals, implants, restoration-margin discrepancies |
| FDA clearance | K210365, "Second Opinion," ~March 2022 (per third-party trackers, not independently re-verified against FDA.gov) |
| Payer-facing capability | None found; provider-side detection only |
| Integrations | Imaging: DEXIS, Carestream, Romexis, Sidexis, Apteryx XVWeb, MiPACS, SOTA Cloud, Tab32, Vatech, Medit. PMS: Open Dental, Eaglesoft, Curve, Dentally, Dentrix, Planet DDS, Patterson Dental, CareStack, Denticon, ClearDent |
| Funding and maturity | $58M Series B, Aug 2024 (Left Lane Capital lead, with Smash Capital, Alpha Partners, Craft Ventures, Neotribe Ventures); founder/CEO Ophir Tanz |
| Pricing | $299/month flat rate, free trial available (per Capterra, not confirmed on Pearl's own site) |
| Review | 3.5 · 1 · G2; 4.3 · 4 · Capterra |
Strengths
- One clearance covers a wide range of findings, reducing the "which condition is this cleared for" question other vendors force
- Pricing is actually published, a rarity in this category
- The largest claimed integration list among the chairside-detection competitors
Limits
- No payer-facing claims product found, unlike Overjet's Dental Clarity Network
- Review coverage is thin: 1 G2 review and 4 Capterra reviews for a company that claims the "largest investment ever in dental AI"
- Some Capterra reviewers note false-positive detections despite the broad clearance
Who it's for: practices and small DSOs that want one vendor, one clearance, and a published price rather than a custom quote. Who should skip it: any DSO or payer that specifically needs claims-review or claims-decisioning tooling, since Pearl does not offer one.
2. VideaHealth
Best for: DSOs wanting the deepest clinical validation and the largest named enterprise customer base among the alternatives.
VideaHealth (videahealth.io), founded in 2018 by CEO Florian Hillen and described by the company as "born from Harvard and MIT AI research," builds FDA-cleared chairside detection AI across three named product lines: Videa Caries Assist, Videa Dental Assist (30+ algorithms, including pediatric caries detection for patients age 3 and up, cleared January 3, 2024), and Videa Perio Assist (K223296, independently confirmed on FDA.gov, cleared February 6, 2023).
How it delivers pathology detection
VideaHealth's models run against 2D X-ray images across a broad set of findings and are positioned around a specific vendor-reported accuracy claim: a 43% reduction in missed cavities and a 15% average reduction in false positives, both stated by the company rather than independently corroborated in this pass.
| Highlighting features | 30+ detection algorithms including pediatric caries (age 3+) · Vendor-cited 43% reduction in missed cavities, 15% reduction in false positives · Named enterprise customers: Heartland Dental, dentalcorp · $40M Series B, Jan 2025, led by Threshold Ventures |
| Clinical/functional scope | Chairside 2D detection across caries, perio, and general dental findings |
| FDA clearance | At least 3 clearances: Videa Caries Assist (~May 2022), Videa Dental Assist (Jan 3, 2024), Videa Perio Assist (K223296, Feb 6 2023, independently confirmed on FDA.gov) |
| Payer-facing capability | None found; provider-side detection only |
| Integrations | Not itemized by name in available sources |
| Funding and maturity | $40M Series B, Jan 28 2025 (Threshold Ventures lead, with Avenir, BAM Corner Point, Spark Capital, Zetta Venture Partners, Pillar VC); total funding to date not disclosed |
| Pricing | Not published, not found |
| Review | No score found on G2 or Capterra |
Strengths
- The largest named enterprise customer roster of any alternative on this list (Heartland Dental, dentalcorp)
- A pediatric-specific caries clearance (age 3+), a narrower use case most competitors do not name
- One clearance (Perio Assist) independently confirmed directly on FDA.gov, not just via a press release
Limits
- No independent review score exists on either G2 or Capterra, a real data gap for a well-funded vendor
- Pricing is not published anywhere found
- No payer-facing claims product, so it does not compete with Overjet's Dental Clarity Network side
Who it's for: multi-location DSOs that want a vendor with named enterprise references and pediatric-specific coverage. Who should skip it: buyers who need to see independent review scores before committing, since none currently exist.
3. Denti.AI
Best for: practices wanting panoramic-film disease detection specifically, alongside automated charting.
Denti.AI (denti.ai), founded in 2017 in Toronto by CEO Dmitry Tuzoff, runs two linked FDA-cleared product lines: Denti.AI Auto-Chart (tooth detection, numbering, and charting automation, cleared December 13, 2022, the first FDA-cleared AI dental auto-charting software) and Denti.AI Detect (caries, bone loss, and periapical lesion detection on both panoramic and intraoral film, cleared October 25, 2023). The company also offers a separate AI perio-charting and scribe product, Denti.AI Voice.
How it delivers pathology detection
Denti.AI Detect is, by the vendor's own account, the only company cleared for all three major dental concerns (caries, bone loss, periapical lesions) and the first cleared for panoramic-film disease detection specifically, a film type most competitors do not cover. A vendor-cited study reports 26% extra treatment opportunities identified across 24 dentists.
| Highlighting features | First FDA-cleared AI auto-charting software (Auto-Chart) · Only vendor cleared for panoramic-film disease detection specifically (Detect) · Vendor-cited 70% reduction in charting time/effort · 10,000+ dental professionals served, vendor-claimed |
| Clinical/functional scope | Auto-Chart: tooth detection, numbering, charting automation. Detect: caries, bone loss, periapical lesions on panoramic AND intraoral film |
| FDA clearance | 2 clearances: Auto-Chart (Dec 13 2022), Detect (Oct 25 2023); both via vendor press releases, not independently re-verified against FDA.gov this pass |
| Payer-facing capability | None found; provider-side detection and charting only |
| Integrations | "10+ practice management systems" claimed, not itemized by name |
| Funding and maturity | Founders and funding amount not disclosed in available sources; 10,000+ professionals served, vendor-claimed |
| Pricing | Not disclosed by vendor; one third-party review site (review.dental) headlines it as "the price disruptor at $49," explicitly a third-party claim, not vendor-confirmed |
| Review | 4.9 · 8 · Capterra, but that score is for the separate Denti.AI Voice/scribe product, not for Detect, the imaging-AI product profiled here. No independent score found for Detect itself |
Strengths
- Panoramic-film disease detection is a genuine point of differentiation most competitors do not offer
- One clearance covers three major concerns at once (caries, bone loss, periapical lesions)
- Bundles charting automation and imaging detection under one vendor relationship
Limits
- Neither K-number was independently re-verified against FDA.gov this pass, unlike Overjet's and VideaHealth's partial confirmation
- The widely cited "$49/month" price is a third-party claim, not something Denti.AI publishes itself
- The 4.9/5 Capterra score belongs to Denti.AI Voice, not to the Detect imaging product being compared to Overjet here
Who it's for: practices that rely heavily on panoramic film and want charting automation bundled in. Who should skip it: buyers pricing decisions on that widely repeated "$49/month" figure, since it is not vendor-confirmed.
4. Velmeni (V4D)
Best for: practices open to a newer, thinly documented entrant with a real FDA clearance.
Velmeni's V4D ("Velmeni for Dentists") is an AI tool that detects cavities, fillings, and implants from X-rays, cleared by the FDA in September 2024 and also approved in Canada and New Zealand. It is the thinnest-documented vendor in this list: founders, funding, pricing, reviews, and named integrations were not found anywhere in research.
How it delivers pathology detection
An independent 510(k) tracker (Innolitics) notes Velmeni Inc. holds 2 total clearances, with V4D cleared under a Predetermined Change Control Plan that cites Overjet's own K222746 clearance as a predicate device, meaning Velmeni's clearance pathway literally referenced a prior Overjet filing.
| Highlighting features | Detects cavities, fillings, and implants from X-rays · Cleared in the US, Canada, and New Zealand · FDA clearance pathway cites an Overjet clearance as predicate device |
| Clinical/functional scope | Chairside 2D detection: cavities, fillings, implants |
| FDA clearance | 2 clearances per an independent tracker (Innolitics); V4D cleared Sept 2024 under a Predetermined Change Control Plan citing Overjet's K222746 as predicate |
| Payer-facing capability | Not found |
| Integrations | Not found |
| Funding and maturity | Founders and funding not found anywhere in research; the thinnest-documented vendor in this set |
| Pricing | Not found |
| Review | No score found on G2 or Capterra |
Strengths
- A genuine, multi-market FDA/regulatory clearance (US, Canada, New Zealand), not merely a claim
- A real, current alternative rather than an abandoned or rebranded product
Limits
- No founder, funding, pricing, or integration information could be found anywhere in research
- Its own clearance pathway depends on an Overjet filing as predicate device, a direct dependency worth knowing before treating it as fully independent
- No independent review score exists on G2 or Capterra
Who it's for: buyers comfortable evaluating an emerging, small vendor directly rather than relying on published reviews or funding history. Who should skip it: DSOs that require vendor financial stability or reference customers as a purchasing condition.
5. Diagnocat
Best for: practices whose priority is 3D CBCT analysis specifically, not general 2D chairside detection.
Diagnocat (diagnocat.com) is an AI platform built specifically for CBCT (3D) visualization and analysis, positioned around the tagline "CBCT as easy as ABC," plus patient-communication reporting tools. The company states it had already served dental professionals in more than 50 countries before its US launch. A founder is referenced in company materials as Dr. Alex Sanders, though a specific title was not stated in available sources.
How it delivers CBCT analysis
Diagnocat states it has obtained US FDA clearance in a company announcement, though the specific K-number and exact decision date were not disclosed in available page content. This makes it the direct comparison point for Overjet's own CBCT Assist clearance (K251514, Dec 2025) specifically, not for Overjet's broader 2D platform.
| Highlighting features | Purpose-built for 3D CBCT scan analysis, not general 2D film · Patient-communication reporting included · Already serving professionals in 50+ countries before US launch |
| Clinical/functional scope | 3D CBCT visualization and analysis specifically |
| FDA clearance | US clearance stated by the company; specific K-number and decision date not disclosed in available sources |
| Payer-facing capability | Not found |
| Integrations | Not found |
| Funding and maturity | Not found; a founder is referenced as Dr. Alex Sanders, role not specified |
| Pricing | Not found |
| Review | No score found on G2 or Capterra |
Strengths
- The only vendor on this list built specifically for 3D CBCT rather than 2D film
- An established international footprint (50+ countries) before entering the US market
- Patient-communication reporting bundled alongside the diagnostic output
Limits
- The specific FDA K-number and clearance date are not disclosed anywhere found, unlike most other vendors on this list
- Funding, pricing, and independent review scores are not found anywhere in research
- It does not address 2D chairside detection, so it cannot replace a Pearl, VideaHealth, or Denti.AI purchase on its own
Who it's for: practices and imaging centers whose primary volume is CBCT scans rather than 2D bitewing/periapical film. Who should skip it: practices without meaningful CBCT volume, since 2D detection is not this product's focus.
6. Orca Dental AI (CephX)
Best for: orthodontic practices needing cephalometric analysis specifically, not caries or perio detection.
Orca Dental AI, an Israeli startup, builds CephX, an AI-assisted cephalometric analysis tool for orthodontic X-rays, covering diagnosis, treatment planning, and simulation for patients age 14 and older. This is a narrower, genuinely different clinical use case than the general caries, perio, and bone-loss detection most of this list competes on.
How it delivers cephalometric analysis
CephX was cleared under that name on January 28, 2024, per an independent tracker not independently re-verified against FDA.gov this pass. We are presenting this vendor explicitly as a different clinical use case, a niche specialist, not a head-to-head Overjet substitute.
| Highlighting features | AI-assisted cephalometric diagnosis, treatment planning, and simulation · For orthodontic X-rays specifically, patients age 14+ · Israeli startup per a startup-directory listing |
| Clinical/functional scope | Orthodontic cephalometric analysis, a different workflow than caries/perio/bone-loss detection |
| FDA clearance | CephX cleared Jan 28 2024 per an independent tracker, not independently re-verified against FDA.gov |
| Payer-facing capability | Not found |
| Integrations | Not found |
| Funding and maturity | Founders and funding not found; only aggregator profile pages surfaced |
| Pricing | Not found |
| Review | No score found on G2 or Capterra |
Strengths
- A real, named FDA clearance for a specific, well-defined orthodontic use case
- Fills a niche (cephalometric analysis) that none of the general chairside-detection vendors on this list address
Limits
- Does not compete on caries, perio, or bone-loss detection at all, the core use case most buyers researching "Overjet alternatives" actually want
- Founders, funding, pricing, and reviews were not found in available sources
- The FDA clearance date was not independently re-verified against FDA.gov this pass
Who it's for: orthodontic practices specifically needing cephalometric AI, as a complement to, not a replacement for, a general chairside detection tool. Who should skip it: general dental practices looking for caries or perio detection, since that is not what CephX does.
7. Adravision (Adra)
Best for: early adopters wanting a vendor that explicitly targets clinics, DSOs, and payers at once.
Adravision (adra.ai), a Y Combinator S21 company founded in 2021 in Atlanta, is one of the very few vendors on this list besides Overjet itself to explicitly target three segments at once: dental clinics, DSOs, and the insurance/payer sector. No FDA 510(k) clearance was found for this vendor, so it should be treated as not FDA-cleared unless the vendor states otherwise.
How it delivers payer-facing claims support
Adravision's positioning is the closest match on this list to Overjet's own payer-side ambition, but at a vastly smaller scale: roughly $230,000 total raised, most recently a Seed-II round of approximately $100,000, against Overjet's stated $130 million-plus raised.
| Highlighting features | Targets clinics, DSOs, and payers all at once · Y Combinator S21 batch · Founded 2021, Atlanta, GA |
| Clinical/functional scope | Not detailed in available sources; positioned around the payer/claims angle rather than a named detection algorithm list |
| FDA clearance | None found; treat as not FDA-cleared unless the vendor states otherwise |
| Payer-facing capability | Explicitly targets the payer/insurance sector, the closest match on this list to Overjet's own Dental Clarity Network ambition |
| Integrations | Not found |
| Funding and maturity | Approximately $230K total raised, most recent round approximately $100K (Seed-II stage); an early-stage, watch-list name |
| Pricing | Not found |
| Review | No score found on G2 or Capterra |
Strengths
- One of only two vendors in this entire list (with Overjet itself) explicitly targeting the payer side
- A legitimate YC-backed startup with a clear three-segment go-to-market thesis
Limits
- No confirmed FDA clearance, unlike every chairside-detection vendor on this list
- At roughly $230K raised, its scale is a small fraction of Overjet's $130 million-plus
- Pricing, integrations, and reviews were not found anywhere in research
Who it's for: early adopters and innovation-minded buyers comfortable evaluating an emerging, small vendor with a genuine payer-side thesis. Who should skip it: buyers who require an FDA-cleared product or an established funding history before purchase.
8. Dental Monitoring
Best for: orthodontic practices wanting AI-based remote monitoring between patient visits, a different workflow entirely.
Dental Monitoring (dental-monitoring.com), founded in 2014 in Paris by Philippe Salah (CEO), Armelle Coquart, and Emmanuel Salah, is a 501-1,000 employee company (per Crunchbase) whose AI monitors orthodontic treatment progress between visits: patients use a mobile app to send images, and the AI flags progress and compliance for the clinician.
How it delivers remote monitoring
This is a fundamentally different workflow from Overjet's chairside pathology detection or payer claims analytics, and we are framing it explicitly as a different use case (orthodontic remote monitoring), not a like-for-like substitute for Overjet's imaging platform.
| Highlighting features | Patient mobile app sends images between orthodontic visits · AI flags treatment progress and compliance for the clinician · 501-1,000 employees (Crunchbase band) · Lead investor: Lazard Elaia Capital |
| Clinical/functional scope | Remote, between-visit orthodontic treatment monitoring, not chairside pathology detection |
| FDA clearance | Not applicable; a different regulatory profile than chairside imaging-detection AI |
| Payer-facing capability | Not found |
| Integrations | Not found |
| Funding and maturity | Lead investor Lazard Elaia Capital; total amount not disclosed; founded 2014, Paris, France |
| Pricing | Contact vendor for pricing; no free trial |
| Review | 0.0 · 0 · Capterra |
Strengths
- A mature, established company (founded 2014, 501-1,000 employees) with a clear and specific use case
- Solves a real gap (between-visit monitoring) that chairside detection tools do not address at all
Limits
- Zero Capterra reviews despite the company's scale, an unusual gap for a business this size
- No published pricing and no free trial, unlike several smaller competitors on this list
- Does not perform caries, perio, or bone-loss detection at all, so it cannot substitute for Overjet's core imaging function
Who it's for: orthodontic practices specifically wanting remote, between-visit patient monitoring. Who should skip it: anyone searching for a chairside pathology-detection or payer-claims alternative to Overjet, since this solves a different problem entirely.
9. KELLS
Best for: consumers wanting a discounted dentist network and virtual triage, not a practice, DSO, or payer buying an imaging or claims platform.
KELLS (getkells.com), founded in 2018 in Long Island City, NY, by co-founder and COO Kevin Duffy-Acevedo, is a consumer membership platform, explicitly not dental insurance, offering AI-powered virtual triage and checkups plus access to a discounted direct-pay dentist network the company claims covers 70,000-plus dentists nationwide. This is a different market segment than every other vendor on this list, and we are flagging that prominently rather than presenting it as a like-for-like substitute.
How it delivers consumer triage
KELLS' only feature that resembles Overjet's category at all is Treatment Validation, an AI-assisted second-opinion feature on proposed treatment plans. The rest of the product, membership tiers, a discount dentist network, and consumer telehealth triage, is a consumer discount-membership and telehealth business, not enterprise imaging or claims-decisioning AI sold to practices, DSOs, or payers.
| Highlighting features | AI-powered virtual triage and checkups for consumers · 70,000+ dentist discount network claimed · Treatment Validation: AI-assisted second opinions on proposed treatment plans · Three tiers: Free/Basic, Premium, Complete |
| Clinical/functional scope | Consumer-facing triage and treatment-plan second opinions, not chairside imaging AI or payer claims decisioning |
| FDA clearance | None found; not applicable to this product category |
| Payer-facing capability | None; explicitly "not dental insurance" |
| Integrations | Not found; consumer-facing product, not a PMS/imaging integration |
| Funding and maturity | Angel-stage funding; investor R/GA Ventures; total not disclosed; founded 2018 |
| Pricing | Free/Basic tier; Premium $99/year; Complete $149/year ("25-85% savings on procedures," vendor-stated) |
| Review | No score found on G2 or Capterra |
Strengths
- A large claimed discount-dentist network (70,000+) for consumers seeking direct-pay savings
- Published, transparent consumer pricing tiers, unlike most B2B vendors on this list
Limits
- This is a consumer product, not something a practice, DSO, or payer purchases as an imaging or claims platform
- No FDA clearance and no chairside imaging-detection capability at all
- Surfaces in some "Overjet alternative" searches despite serving a different buyer and a different job entirely
Who it's for: individual consumers wanting a discounted dentist network and virtual triage. Who should skip it: practices, DSOs, or payers evaluating chairside imaging AI or claims-decisioning platforms, since KELLS is not that product.
10. Zentist
Best for: DSOs wanting revenue-cycle-management automation, a different job than imaging AI or payer claims decisioning.
Zentist (zentist.io) provides dental revenue-cycle-management automation for DSOs: automated claims submission, posting, and accounts-receivable follow-up. This is billing and claims operations automation, not imaging AI and not the payer-side claims-decisioning AI that Overjet's ReviewPASS and Dental Clarity Network provide.
How it delivers revenue-cycle automation
Zentist automates the operational mechanics of getting claims submitted, posted, and followed up on for DSOs. It shares the word "AI" and the word "claims" with Overjet's marketing language, but the underlying job, billing operations versus clinical detection and claims-decisioning, is different, and we are framing that explicitly rather than presenting it as a head-to-head Overjet substitute.
| Highlighting features | Automated claims submission for DSOs · Automated payment posting · Automated accounts-receivable follow-up |
| Clinical/functional scope | None; this is billing and RCM operations automation, not clinical imaging or pathology detection |
| FDA clearance | None found / not applicable; not a clinical device |
| Payer-facing capability | Automates the DSO side of claims operations; does not perform payer-side claims-decisioning the way Overjet's ReviewPASS/Dental Clarity Network does |
| Integrations | Not found |
| Funding and maturity | Founders and funding not found in available sources |
| Pricing | Not published; enterprise RCM pricing is typically custom-quoted |
| Review | No score found on G2 or Capterra |
Strengths
- Addresses a real, costly DSO pain point (claims submission, posting, A/R follow-up) that none of the imaging-AI vendors on this list touch
- Purpose-built for DSO-scale billing operations rather than a general small-practice tool
Limits
- Does no imaging analysis and no chairside pathology detection at all
- Its claims-automation focus is operational (submission, posting, A/R), not the payer-side claims-decisioning Overjet's ReviewPASS performs
- Founders, funding, and pricing were not found anywhere in research
Who it's for: DSOs specifically looking to automate claims submission, posting, and A/R follow-up as a billing operations upgrade. Who should skip it: anyone searching for imaging AI or payer-side claims-decisioning to replace Overjet, since Zentist does neither.
Top 10 Overjet Alternatives Pricing in Detail
Where a vendor states a specific accuracy or time-savings figure on its own site, we show that figure alongside pricing rather than dropping it, since it is the closest thing to a stated value claim most of these vendors publish.
| Company | Commercial model | Published price | Vendor's own performance claim (as stated) |
|---|---|---|---|
| Pearl | Flat monthly subscription (per Capterra, not vendor-confirmed on Pearl's own site) | $299/month (per Capterra), free trial available | No vendor-published accuracy or time-savings percentage found |
| VideaHealth | Not published, contact vendor | Not published | "43% reduction in missed cavities" and "15% average reduction in false positives" (vendor-stated) |
| Denti.AI | Not published for Detect; Voice/scribe product priced separately | Not published ("$49/month" per one third-party review site, not vendor-confirmed) | "70% reduction in time/effort" for Auto-Chart; "26% extra treatment opportunities" across 24 dentists for Detect (vendor-stated) |
| Velmeni (V4D) | Not found | Not found | Not found |
| Diagnocat | Not found | Not found | No performance percentage found; "CBCT as easy as ABC" positioning only |
| Orca Dental AI (CephX) | Not found | Not found | Not found |
| Adravision | Not published | Not found | Not found |
| Dental Monitoring | Contact vendor for pricing (per Capterra) | Not published, no free trial | Not found |
| KELLS | Consumer membership tiers | Free/Basic; Premium $99/year; Complete $149/year ("25-85% savings on procedures," vendor-stated) | "70,000+ dentists nationwide" network size (vendor-stated) |
| Zentist | Enterprise RCM, typically custom-quoted | Not published | Not found |
"Not found" means no figure surfaced in research, vendor or third-party. This is not the same as "$0" or "free."
Not All Overjet Alternatives Are the Same Kind of Tool
Five of these ten vendors compete head-to-head with Overjet on chairside 2D pathology detection. The rest solve a genuinely different problem, and treating them as interchangeable is the single most common mistake in searches for this keyword.
| Category | What it is | Who is in it | What to ask |
|---|---|---|---|
| Chairside/clinical imaging AI | FDA-cleared AI that reads 2D X-ray film for caries, bone loss, calculus, and periapical findings, the true head-to-head competitor set for Overjet's core provider-side product | Pearl · VideaHealth · Denti.AI · Velmeni | Which specific pathologies are covered under one clearance versus several, and on which film types? |
| 3D/CBCT-specific imaging AI | AI built specifically for 3D CBCT scan visualization and analysis, rather than 2D chairside film | Diagnocat | Does it also handle 2D films, or is it CBCT only? |
| Niche/specialist clinical AI | AI for a narrower clinical workflow, cephalometric analysis or remote between-visit ortho monitoring, that does not compete head-to-head with caries or perio detection | Orca Dental AI (CephX) · Dental Monitoring | Does this actually replace or complement a chairside detection tool? |
| Early-stage payer-facing AI | An AI-native platform targeting clinics, DSOs, and payers at once, the closest thesis match to Overjet's own payer-side ambition, at a far earlier funding stage | Adravision | What is actually live in production today versus on the roadmap? |
| Adjacent-but-different category | Tools that surface in "Overjet alternative" searches but solve a different problem: consumer discount membership, or revenue-cycle billing automation | KELLS · Zentist | Does this tool perform imaging AI or claims-decisioning AI at all, or something else entirely? |
Which Overjet Alternative Fits Your Practice Type
This table genuinely rules some vendors out for some segments. A table where one vendor wins every row is not a credible fit assessment.
| Practice/organization type | Choose | Skip |
|---|---|---|
| Solo or small general practice wanting one clearance and a published price | Pearl, for its single broad clearance and flat published rate | VideaHealth or Denti.AI, since neither publishes pricing |
| Multi-location DSO wanting named enterprise references | VideaHealth, for its Heartland Dental and dentalcorp customer references | Velmeni or Orca Dental AI, since neither discloses named customers |
| Practice relying heavily on panoramic film | Denti.AI, the only vendor cleared for panoramic-film disease detection specifically | Pearl or VideaHealth, whose clearances are not described as panoramic-specific |
| Imaging center or practice with significant CBCT volume | Diagnocat, purpose-built for 3D CBCT analysis | Pearl, VideaHealth, or Denti.AI, all built around 2D film |
| Orthodontic-only practice | Orca Dental AI for cephalometric analysis, or Dental Monitoring for between-visit remote monitoring, depending on which workflow you need | Any general chairside caries/perio detection vendor, since neither replaces the other |
| DSO or group evaluating a payer-facing claims angle | Adravision, at an early stage, or Overjet itself, at a far larger scale | KELLS or Zentist, neither of which performs payer-side claims-decisioning |
| DSO whose actual pain point is billing and A/R, not imaging | Zentist, for revenue-cycle-management automation | Any imaging-detection vendor on this list, since none of them touch billing operations |
| Individual consumer wanting a discounted dentist network | KELLS | Any vendor on this list sold to practices, DSOs, or payers, since KELLS is the only consumer-facing product here |
If your practice's actual need is general chairside caries and perio detection, the real Overjet head-to-head set is Pearl, VideaHealth, Denti.AI, and Velmeni. Every other row above is a different tool solving a different problem, not a weaker version of the same one.
FDA Clearance Claims: What Is Actually Corroborated
Independent FDA-clearance-count verification for this category is inconsistent across every source, including the vendor's own PR. This table states what could be independently confirmed on FDA.gov versus what could not, rather than repeating any single vendor's self-reported count.
| Vendor | Best-confirmed clearance count | Vendor/third-party claim | Note |
|---|---|---|---|
| Overjet | 9, independently confirmed directly against FDA.gov's 510(k) database (K210187 through K253930, 2021-2026) | Overjet's own PR calls its Dec 2025 clearance the "10th"; a third-party review site claims "7" | A three-way discrepancy across the vendor, a reviewer, and our own independent count |
| Pearl | 1 broad clearance (K210365, "Second Opinion") | Same, per third-party trackers | Not independently re-verified against FDA.gov this pass |
| VideaHealth | At least 3 | 1 (Videa Perio Assist, K223296) independently confirmed on FDA.gov; the other 2 via press releases and trackers | Partial independent confirmation, better than most vendors on this list |
| Denti.AI | 2 (Auto-Chart, Detect) | Vendor press releases | Not independently re-verified against FDA.gov this pass |
| Velmeni | 2, per an independent tracker (Innolitics) | Same | One clearance cites an Overjet filing (K222746) as predicate device |
| Diagnocat | 1 claimed | Company announcement | K-number and exact decision date not disclosed |
| Orca Dental AI (CephX) | 1 | Third-party tracker only | Not independently re-verified against FDA.gov |
| Adravision | None found | Not applicable | Treat as not FDA-cleared unless the vendor states otherwise |
| Dental Monitoring | Not applicable | Not applicable | A different regulatory profile than imaging-detection AI |
| KELLS | None found | Not applicable | Not applicable to this consumer product category |
8 Things Worth Checking Before You Choose Any Overjet Alternative
| What to check | Why it matters |
|---|---|
| CareStack is not an Overjet competitor | CareStack's own "AI Suite" runs on Overjet's FDA-cleared AI under a named "Smart Dental Platform" partnership since April 2025. It is a distribution partner, not an independent alternative, and should not appear on a genuine "Overjet alternatives" list |
| Overjet's own FDA clearance count is disputed across three sources | 9 independently confirmed on FDA.gov, Overjet's own PR calling its Dec 2025 clearance the "10th," and a third-party review site citing "7." Ask which number a source actually verified before repeating it |
| Review-platform coverage across this entire category is thin | Even Overjet, the best-funded vendor here, has just 1 review on each of G2 and Capterra, and the two scores contradict each other (0.0/5 versus 5.0/5). Do not assume mature-SaaS-category review volume anywhere in this space |
| Denti.AI's 4.9/5 Capterra score belongs to a different product | That score is for Denti.AI Voice, a scribe product, not for Denti.AI Detect, the imaging-AI product actually being compared to Overjet |
| KELLS is a consumer product, not a practice or DSO tool | It is a discount-membership and telehealth-triage platform, explicitly "not dental insurance," despite surfacing in some Overjet-alternative searches |
| Zentist is billing automation, not imaging AI | It automates claims submission, posting, and A/R follow-up for DSOs, a different job than pathology detection or payer-side claims decisioning, despite overlapping marketing language |
| Velmeni's own FDA clearance pathway cites an Overjet filing as predicate device | This is a direct regulatory dependency worth knowing before treating Velmeni as a fully independent competitor |
| Several vendors on this list have no independently confirmed founder, funding, or pricing information | Velmeni, Diagnocat, Orca Dental AI, and Adravision all have real documentation gaps. Ask directly rather than assuming the gap means something specific |
A 12-Question Checklist Before You Choose Any Overjet Alternative
- Which specific pathologies or findings does the AI detect, and on which film types (bitewing, periapical, panoramic, CBCT)?
- Is the clearance a single broad FDA filing or several narrower ones, and can you verify the K-number directly on FDA.gov?
- Does the vendor serve only the provider side, or does it also offer a payer-facing claims product?
- Which practice management and imaging systems does it integrate with, by name, not just "PMS-agnostic"?
- What is the published price, and does it change with patient volume or number of locations?
- Is the review score you are looking at for the exact product being pitched, or for a related product from the same company?
- Is the review platform a customer-review site (G2, Capterra) or an employee-review site (Glassdoor), and are you comparing the right kind?
- Who funded the company, how much, and how recently, as a proxy for its staying power?
- Is the vendor an independent company, or does its FDA clearance depend on another vendor's device as a predicate?
- What does the vendor claim for accuracy or time savings, and is that claim from an independent study or the vendor's own marketing?
- Does the tool address your actual clinical workflow (2D chairside, 3D CBCT, ortho monitoring, cephalometric analysis) or a different one entirely?
- If pricing is not published, what is the actual quote you receive after a demo, and how does it compare across at least two vendors on this list?
How Needletail Approaches This
Needletail AI does not compete in the AI-powered imaging category covered by this comparison; its platform focuses on eligibility and benefits verification. For that adjacent workflow, see Needletail's eligibility and benefits verification service, or open the interactive demo to see a live verification run against a real payer portal.
About the Author
Georgey Jacob writes on dental industry structure for PipeRocket Digital, covering how dental AI, imaging, billing, and credentialing vendors are actually organized, funded, and regulated, so that practices and DSOs can evaluate them past the marketing copy.







